341 related articles for article (PubMed ID: 32112852)
1. Ultrasound-responsive neurotrophic factor-loaded microbubble- liposome complex: Preclinical investigation for Parkinson's disease treatment.
Lin CY; Lin YC; Huang CY; Wu SR; Chen CM; Liu HL
J Control Release; 2020 May; 321():519-528. PubMed ID: 32112852
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive, neuron-specific gene therapy by focused ultrasound-induced blood-brain barrier opening in Parkinson's disease mouse model.
Lin CY; Hsieh HY; Chen CM; Wu SR; Tsai CH; Huang CY; Hua MY; Wei KC; Yeh CK; Liu HL
J Control Release; 2016 Aug; 235():72-81. PubMed ID: 27235980
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-triggered effects of the microbubbles coupled to GDNF- and Nurr1-loaded PEGylated liposomes in a rat model of Parkinson's disease.
Yue P; Gao L; Wang X; Ding X; Teng J
J Cell Biochem; 2018 Jun; 119(6):4581-4591. PubMed ID: 29240240
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive, Targeted, and Non-Viral Ultrasound-Mediated GDNF-Plasmid Delivery for Treatment of Parkinson's Disease.
Fan CH; Ting CY; Lin CY; Chan HL; Chang YC; Chen YY; Liu HL; Yeh CK
Sci Rep; 2016 Jan; 6():19579. PubMed ID: 26786201
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease.
Sun M; Kong L; Wang X; Lu XG; Gao Q; Geller AI
Brain Res; 2005 Aug; 1052(2):119-29. PubMed ID: 16018990
[TBL] [Abstract][Full Text] [Related]
6. Focused ultrasound-induced blood brain-barrier opening enhanced vascular permeability for GDNF delivery in Huntington's disease mouse model.
Lin CY; Tsai CH; Feng LY; Chai WY; Lin CJ; Huang CY; Wei KC; Yeh CK; Chen CM; Liu HL
Brain Stimul; 2019; 12(5):1143-1150. PubMed ID: 31079989
[TBL] [Abstract][Full Text] [Related]
7. Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease.
Pak ME; Ahn SM; Jung DH; Lee HJ; Ha KT; Shin HK; Choi BT
J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):712-721. PubMed ID: 31644786
[TBL] [Abstract][Full Text] [Related]
8. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
[TBL] [Abstract][Full Text] [Related]
9. Gene Therapy in the Management of Parkinson's Disease: Potential of GDNF as a Promising Therapeutic Strategy.
Behl T; Kaur I; Kumar A; Mehta V; Zengin G; Arora S
Curr Gene Ther; 2020; 20(3):207-222. PubMed ID: 32811394
[TBL] [Abstract][Full Text] [Related]
10. Novel Focused Ultrasound Gene Therapy Approach Noninvasively Restores Dopaminergic Neuron Function in a Rat Parkinson's Disease Model.
Mead BP; Kim N; Miller GW; Hodges D; Mastorakos P; Klibanov AL; Mandell JW; Hirsh J; Suk JS; Hanes J; Price RJ
Nano Lett; 2017 Jun; 17(6):3533-3542. PubMed ID: 28511006
[TBL] [Abstract][Full Text] [Related]
11. Focused ultrasound-induced blood-brain barrier opening for non-viral, non-invasive, and targeted gene delivery.
Lin CY; Hsieh HY; Pitt WG; Huang CY; Tseng IC; Yeh CK; Wei KC; Liu HL
J Control Release; 2015 Aug; 212():1-9. PubMed ID: 26071631
[TBL] [Abstract][Full Text] [Related]
12. Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.
Migliore MM; Ortiz R; Dye S; Campbell RB; Amiji MM; Waszczak BL
Neuroscience; 2014 Aug; 274():11-23. PubMed ID: 24845869
[TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor are required simultaneously for survival of dopaminergic primary sensory neurons in vivo.
Erickson JT; Brosenitsch TA; Katz DM
J Neurosci; 2001 Jan; 21(2):581-9. PubMed ID: 11160437
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons.
Wu X; Chen PS; Dallas S; Wilson B; Block ML; Wang CC; Kinyamu H; Lu N; Gao X; Leng Y; Chuang DM; Zhang W; Lu RB; Hong JS
Int J Neuropsychopharmacol; 2008 Dec; 11(8):1123-34. PubMed ID: 18611290
[TBL] [Abstract][Full Text] [Related]
15. Localized delivery of curcumin into brain with polysorbate 80-modified cerasomes by ultrasound-targeted microbubble destruction for improved Parkinson's disease therapy.
Zhang N; Yan F; Liang X; Wu M; Shen Y; Chen M; Xu Y; Zou G; Jiang P; Tang C; Zheng H; Dai Z
Theranostics; 2018; 8(8):2264-2277. PubMed ID: 29721078
[No Abstract] [Full Text] [Related]
16. Potential Therapeutic Approach using Aromatic l-amino Acid Decarboxylase and Glial-derived Neurotrophic Factor Therapy Targeting Putamen in Parkinson's Disease.
Tripathi RK; Goyal L; Singh S
Curr Gene Ther; 2024; 24(4):278-291. PubMed ID: 38310455
[TBL] [Abstract][Full Text] [Related]
17. Application of a blood-brain-barrier-penetrating form of GDNF in a mouse model for Parkinson's disease.
Dietz GP; Valbuena PC; Dietz B; Meuer K; Müeller P; Weishaupt JH; Bähr M
Brain Res; 2006 Apr; 1082(1):61-6. PubMed ID: 16703672
[TBL] [Abstract][Full Text] [Related]
18. Enhanced brain-derived neurotrophic factor delivery by ultrasound and microbubbles promotes white matter repair after stroke.
Rodríguez-Frutos B; Otero-Ortega L; Ramos-Cejudo J; Martínez-Sánchez P; Barahona-Sanz I; Navarro-Hernanz T; Gómez-de Frutos Mdel C; Díez-Tejedor E; Gutiérrez-Fernández M
Biomaterials; 2016 Sep; 100():41-52. PubMed ID: 27240161
[TBL] [Abstract][Full Text] [Related]
19. Adenoviral vector-mediated delivery of glial cell line-derived neurotrophic factor provides neuroprotection in the aged parkinsonian rat.
Connor B
Clin Exp Pharmacol Physiol; 2001 Nov; 28(11):896-900. PubMed ID: 11703392
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral gene transfer of BDNF and GDNF synergistically prevent motoneuron loss in the nucleus ambiguus.
Moro K; Shiotani A; Watabe K; Takeda Y; Saito K; Mori Y; Ogawa K
Brain Res; 2006 Mar; 1076(1):1-8. PubMed ID: 16473328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
